Home/Pipeline/hTERT ICC Test

hTERT ICC Test

Bladder Cancer (adjunct to urine cytology)

CommercialActive

Key Facts

Indication
Bladder Cancer (adjunct to urine cytology)
Phase
Commercial
Status
Active
Company

About INOVIQ

Australian cancer‑diagnostics and exosome‑therapeutics company with commercial assays and a growing pipeline.

View full company profile

Therapeutic Areas